Dr. Paul M Yonover , MD
Urology • Chicago, IL
1011 W Wellington Ave, Ste 200
Chicago, IL 606574325
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 19, 2005; this date does not establish years in practice.
-
Published CMS data list 4,093 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1952 — Leuprolide injectable, camcevi, 1 mg: 882 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 559 service units.
- 99214 — Established patient outpatient office visit: 481 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 27 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,616 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 546 prescription fills, including refills.
- Finasteride — 361 prescription fills, including refills.
- Myrbetriq (Mirabegron) — 106 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: 573. Middle half: 187 to 1,871.
More Medicare Part B services than 70% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: 1,869. Middle half: 703 to 4,858.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,877 in 2020 to 4,093 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1011 W Wellington Ave
Ste 200
Chicago, IL 606574325
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Uropartners Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Icahn School Of Medicine At Mount Sinai
1997
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
452 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $270,079 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $203,560 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,386 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$381,196 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $96,396.22 across 151 records.
By nature of payment (3 largest of 5)
- Consulting Fee: $75,795.50 across 19 records.
- Travel and Lodging: $13,677.62 across 24 records.
- Food and Beverage: $5,903.79 across 106 records.
Reporting-company totals (3 largest of 27)
- Telix Pharmaceuticals: $81,128.58 across 68 records.
- ACCORD HEALTHCARE, INC.: $8,050.00 across 2 records.
- Ferring Pharmaceuticals Inc.: $2,985.04 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
29 years (graduated 1997)
CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Yonover has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Yonover as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: 573. Middle half: 187 to 1,871.
More Medicare Part B services than 70% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: 1,869. Middle half: 703 to 4,858.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: $62,507. Middle half: $17,593 to $147,521.
A higher Medicare-allowed amount than 75% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $150,002. Middle half: $69,734 to $268,150.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Chicago, IL (2024, 66 clinicians with data). Median for this group: $47,277. Middle half: $13,074 to $104,973.
A higher Medicare payment amount than 75% of clinicians listed under Urology in Illinois (2024, 313 clinicians with data). Median for this group: $113,671. Middle half: $51,216 to $199,881.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Urology in Chicago, IL (2024, 97 clinicians with data). Median for this group: 95. Middle half: 44 to 460.
More Part D prescriptions than 65% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: 813. Middle half: 123 to 1,932.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in Chicago, IL (2024, 97 clinicians with data). Median for this group: $4,095. Middle half: $289 to $55,751.
A higher Part D drug cost than 75% of clinicians listed under Urology in Illinois (2024, 381 clinicians with data). Median for this group: $79,867. Middle half: $8,053 to $301,934.
193 active clinicians are listed under Urology with a practice address in Chicago, IL (629 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chicago
29.5% of these 193 clinicians have the CMS telehealth indicator.
40.4% of these 193 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 118% from 1,877 in 2020 to 4,093 in 2024.
- 2020: 1,877
- 2021: 2,324
- 2022: 2,691
- 2023: 3,124
- 2024: 4,093
-
Medicare-allowed amount
Medicare-allowed amount increased 120% from $122,695 in 2020 to $270,079 in 2024.
- 2020: $122,695
- 2021: $167,683
- 2022: $229,906
- 2023: $241,383
- 2024: $270,079
-
Paid by Medicare
Paid by Medicare increased 132% from $87,819 in 2020 to $203,560 in 2024.
- 2020: $87,819
- 2021: $121,045
- 2022: $170,266
- 2023: $181,305
- 2024: $203,560
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 35% from 1,196 in 2020 to 1,616 in 2024.
- 2020: 1,196
- 2021: 1,532
- 2022: 1,448
- 2023: 1,403
- 2024: 1,616
-
30-day fills
30-day fills increased 46% from 2,322 in 2020 to 3,386 in 2024.
- 2020: 2,322
- 2021: 3,181
- 2022: 3,197
- 2023: 3,202
- 2024: 3,386
-
Part D drug cost
Part D drug cost decreased 41% from $641,224 in 2020 to $381,196 in 2024.
- 2020: $641,224
- 2021: $795,472
- 2022: $432,571
- 2023: $269,642
- 2024: $381,196
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 4301% from $2,190.49 in 2021 to $96,396.22 in 2025.
- 2021: $2,190.49
- 2022: $2,609.14
- 2023: $18,950.50
- 2024: $12,619.50
- 2025: $96,396.22
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 151 records totaling $96,396.22.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $9,750.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $9,750.00 |
| ACCORD HEALTHCARE, INC. |
Consulting Fee
Cash or cash equivalent
|
Camcevi | General | $7,350.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
— | General | $6,375.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $4,875.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $4,875.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $4,500.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $4,500.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $4,000.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $3,750.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
— | General | $3,375.00 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $2,800.71 |
| Ferring Pharmaceuticals Inc. |
Consulting Fee
Cash or cash equivalent
|
ADSTILADRIN | General | $2,783.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $2,500.00 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $2,007.73 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $1,750.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $1,500.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $1,312.50 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,150.00 |
| Telix Pharmaceuticals |
Consulting Fee
Cash or cash equivalent
|
ILLUCCIX | General | $1,000.00 |
| Telix Pharmaceuticals |
Honoraria
Cash or cash equivalent
|
ILLUCCIX | General | $1,000.00 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $903.50 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $819.92 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $793.80 |
| Telix Pharmaceuticals |
Travel and Lodging
Cash or cash equivalent
|
ILLUCCIX | General | $730.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
882 | 14 | $150.00 | $56.97 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
559 | 308 | $50.00 | $16.86 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
481 | 275 | $228.00 | $132.74 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
317 | 177 | $100.00 | $11.77 |
|
36415
Insertion of needle into vein for collection of blood sample
|
293 | 194 | $20.00 | $8.63 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
247 | 45 | $128.53 | $64.99 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
212 | 143 | $163.00 | $93.88 |
|
51741
Electronic assessment of bladder emptying
|
151 | 95 | $240.00 | $12.13 |
|
81003
Automated urinalysis test
|
151 | 93 | $20.00 | $2.20 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
122 | 83 | $324.00 | $187.92 |
|
64566
Insertion of lower leg neurostimulator electrode
|
115 | 16 | $550.00 | $119.68 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
78 | 36 | $154.00 | $49.66 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
70 | 55 | $930.00 | $241.78 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
45 | 41 | $177.08 | $93.71 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
43 | 38 | $560.00 | $33.54 |
|
55899
Other procedure on male genital system
|
42 | 38 | $1240.00 | $279.26 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
42 | 30 | $40.00 | $5.08 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
38 | 38 | $302.00 | $175.58 |
|
76872
Ultrasound scan of pelvic region through rectum
|
37 | 37 | $590.00 | $137.86 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
36 | 21 | $204.17 | $36.15 |
|
99441
Telephone medical discussion with physician, 5-10 minutes
|
27 | 26 | $100.00 | $58.06 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
26 | 22 | $243.22 | $132.48 |
|
55700
Biopsy of prostate gland
|
20 | 20 | $1010.00 | $138.35 |
|
76872
Ultrasound scan of pelvic region through rectum
|
20 | 20 | $590.00 | $32.52 |
|
51700
Simple bladder irrigation and/or instillation
|
15 | 12 | $380.00 | $79.55 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 546 | 39,327 | $9,271.26 | 165 |
| Finasteride | Finasteride | 361 | 25,992 | $4,678.50 | 94 |
| Myrbetriq | Mirabegron | 106 | 4,770 | $70,901.45 | 22 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 103 | 7,706 | $2,114.11 | 30 |
| Abiraterone Acetate | Abiraterone Acetate | 77 | 2,310 | $174,131.47 | 12 |
| Prednisone | Prednisone | 61 | 2,161 | $324.59 | 13 |
| Potassium Citrate Er | Potassium Citrate | 60 | 3,780 | $9,062.27 | 16 |
| Gemtesa | Vibegron | 44 | 2,100 | $36,541.38 | — |
| Solifenacin Succinate | Solifenacin Succinate | 38 | 2,340 | $901.10 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 30 | 264 | $169.48 | 19 |
| Tadalafil | Tadalafil | 29 | 1,588 | $3,407.43 | — |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 26 | 1,620 | $4,868.65 | — |
| Orgovyx | Relugolix | 22 | 652 | $57,952.26 | — |
| Levofloxacin | Levofloxacin | 21 | 52 | $27.02 | 20 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 18 | 1,376 | $712.38 | — |
| Testosterone | Testosterone | 16 | 718 | $4,235.63 | — |
| Dutasteride | Dutasteride | 16 | 1,305 | $433.86 | — |
| Indapamide | Indapamide | 15 | 750 | $30.96 | — |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | 990 | $270.62 | — |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 12 | 133 | $1,161.79 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20191210002040
WI
1951293943
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Uropartners Llc
836 W Wellington Ave, Chicago, IL 606575147
Phone: 7739751600
Uropartners Llc
1011 W Wellingtron Ave, Chicago, IL 606574325
Phone: 7732811011
Uropartners Llc
2235 Enterprise Dr, Westchester, IL 601545806
Phone: 8479574670
Uropartners Llc
333 Madison St, Joliet, IL 604358200
Phone: 8157257133
Uropartners Llc
350 S Northwest Hwy, Park Ridge, IL 600684262
Phone: 8474701500
Uropartners Llc
2900 N Lake Shore Dr, Chicago, IL 606575640
Phone: 7736653000
Uropartners Llc
1051 Perimeter Dr, Schaumburg, IL 601735075
Phone: 8478233185
Uropartners Llc
836 W Wellington Ave, Chicago, IL 606575640
Phone: 7739751600
Uropartners Llc
1660 Feehanville Dr, Mount Prospect, IL 600566036
Phone: 8478233185
Uropartners Llc
2225 Enterprise Dr, Westchester, IL 601545805
Phone: 7084860076
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated September 19, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Chicago
- Dr. William Lin, MD
- Dr. Nathan Graham, MD
- Dr. Hernan Lescay, MD
- Dr. Minh Pham, MD
- Dr. Roohallah Sharifi, MD
- Dr. Jerome Hoeksema, MD
Mailing Address
1011 W Wellington Ave, Ste 200
Chicago, IL 606574325
Phone: 7732811011